US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist

3.2900
+0.1100+3.46%

Close Jan 3 16:00 ET

3.2900
0.00000.00%

Post 20:01 ET

35.23MMarket Cap-3.02P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marker Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 1.000M	--
--	2024/Q4	-- / 1.000M	--
--	2024/Q3	1.926M / 1.000M	--
--	2024/Q2	1.169M / 0.000	--
--	2024/Q1	1.244M / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 1.000M--

--2024/Q4-- / 1.000M--

--2024/Q31.926M / 1.000M--

--2024/Q21.169M / 0.000--

--2024/Q11.244M / 0.000--

Unlock Free Earnings Estimates

Open Account

Marker Therapeutics Earnings Reports

Marker Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 17:03 ET

Marker Therapeutics | 8-K: Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 14, 2024 16:52 ET

Marker Therapeutics | 8-K: Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates

Aug 14, 2024 16:51 ET

Marker Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 14, 2024 16:44 ET

Analyst Rating

Updated: Dec 31, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall